Twist Bioscience, Inc. (TWST) Company Total Revenue
Robotic DNA synthesis on chips minimizes human error, as evidenced by the company's overall sales. This revenue trend, where the 0.43 metric determines this level, is based on management's expertise in scaling biomanufacturing. The innovative method of creating oligonucleotides guarantees Twist Bioscience (TWST) pricing power, establishing a sustainable defensive moat against the market.
Comprehensive metric breakdowns and analytics for Twist Bioscience, Inc. (TWST)
- market value and analyst target forecast:
- market capitalization details:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Twist Bioscience|TWST - Long-Term Debt to Capital|Current Liabilities to Capital Twist Bioscience Inc|TWST - Company Debts|Debt to Book Value Ratio Twist Bioscience, Inc.|TWST - Company Long-Term Debts|Company Current Liabilities Twist Bioscience|Immediate Liquidity twistbioscience.com
- earnings and market multiples details:
TWST - Net Income|Future Net Profit Twist Bioscience|TWST - Price to Earnings Ratio|Projected Price to Earnings twistbioscience.com|TWST - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Twist Bioscience, Inc.|TWST - Operating profit before deduction of amortization|Earnings per share for the last four quarters Twist Bioscience|TWST - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months twistbioscience.com|TWST - Earnings per share growth in current year|Projected earnings per share growth rate for next year Twist Bioscience
- company sales and revenue statistics:
Comprehensive company analysis:Twist Bioscience Corp TWST
Twist Bioscience (TWST) maintains a monopoly in chip-based DNA synthesis, which creates high market value for its products. This sales data set visualizes the conversion of this technological advantage into actual cash flow. The indicator tracks daily commercial revenue, confirming the factual demand for biomaterials. The steady growth of this metric proves the issuer's investment reliability and operational efficiency. Any negative price action here signals risks of capital impairment.
Key competitors
tempus.com (TEM) - Company Gross Revenue|Company Revenue Qiagen N.V. (QGEN)|IONS - Company Total Revenue|Company Revenue Repligen RGEN|Company Gross Revenue Avidity Biosciences Inc (RNA)|CRISPR Therapeutics Corp - Revenue and Sales Volume|GeneDx Corp (WGS) - Company Sales|RARE: Revenue and Sales Volume|BEAM - Company Gross Revenue|SRPT (Sarepta) - Revenue and Sales Volume|Company Total Revenue 10x Genomics Inc TXG|Company Revenue Intellia (NTLA)|Stoke Corp - Company Sales Volume|Revenue and Sales Volume BLFS (BioLife Solutions, Inc.)|WVE - Company Sales|Maze Therapeutics - Revenue and Sales Volume|Company Total Revenue Sionna Therapeutics, Inc.|PRME (Prime Medicine Corp) - Company Sales|TSHA: Company Total Sales|Company Sales QURE|Company Sales meiragtx.com (MGTX)|Company Revenue REGENXBIO (RGNX)|Company Gross Revenue Solid Biosciences Inc|Ocugen Corp - Company Sales|Company Total Sales PACB (PacBio Corp)|Benitec Biopharma Inc. - Revenue and Sales Volume|DSGN (designtx.com) - Company Sales Volume|Rocket Pharmaceuticals, Inc. (RCKT) - Company Revenue|Company Sales Volume FDMT|LXEO (Lexeo Therapeutics Inc.) - Revenue and Sales Volume|Revenue and Sales Volume Korro Bio, Inc|Company Sales EDIT (Editas Medicine, Inc.)|Company Total Sales SLN|ProQR Therapeutics - Company Sales|CDXS - Company Sales|Sangamo - Revenue and Sales Volume|Company Gross Revenue Nautilus Biotechnology NAUT|Metagenomi, Inc. (MGX) - Company Revenue|DTIL - Company Gross Revenue|Company Sales GBIO|BOLD (Boundless Bio Inc.) - Company Total Sales|Company Sales XCUR (Exicure, Inc.)|IMNN (imunon.com) - Company Sales Revenue|Revenue and Sales Volume PHIO (Phio Pharmaceuticals Corp.)|Mustang Bio Inc - Company Revenue|TransCode - Revenue and Sales Volume|Company Gross Revenue Bionano Genomics, Inc. BNGO|Applied DNA (APDN) - Company Revenue|Company Total Revenue bluebird bio, Inc (BLUE)|Company Revenue ImmunoPrecise Antibodies Ltd|omegatherapeutics.com (OMGA) - Company Gross Revenue|Revenue and Sales Volume OMIC|Company Sales Regulus Therapeutics, Inc. RGLS|Revenue and Sales Volume SYRS (Syros)|Company Gross Revenue Telesis Bio, Inc (TBIO)|TRACON Pharmaceuticals - Revenue and Sales Volume|Company Total Revenue unitybiotechnology.com
